Cargando…
Advances in Drug Discovery of New Antitubercular Multidrug-Resistant Compounds †
Tuberculosis (TB), a disease caused mainly by the Mycobacterium tuberculosis (Mtb), is according to the World Health Organization (WHO) the infectious disease responsible for the highest number of deaths worldwide. The increased number of multidrug-resistant (MDR-TB) and extensively drug-resistant (...
Autores principales: | Fernandes, Guilherme Felipe dos Santos, Man Chin, Chung, Dos Santos, Jean Leandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490408/ https://www.ncbi.nlm.nih.gov/pubmed/28587160 http://dx.doi.org/10.3390/ph10020051 |
Ejemplares similares
-
The Prodrug Approach: A Successful Tool for Improving Drug Solubility
por: Jornada, Daniela Hartmann, et al.
Publicado: (2015) -
Special Issue “Drug Candidates for the Treatment of Infectious Diseases”
por: Man Chin, Chung, et al.
Publicado: (2023) -
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity
por: dos Santos Fernandes, Guilherme Felipe, et al.
Publicado: (2017) -
Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
por: dos Santos, Jean Leandro, et al.
Publicado: (2010) -
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs
por: Lokesh, Dhanashree, et al.
Publicado: (2018)